期刊文献+

抗纤维肌动蛋白抗体阴性的自身免疫性肝炎Ⅰ型患者临床特征分析

The clinical features of autoimmune hepatitis type I patients with negative anti-filamentous actin antibody
下载PDF
导出
摘要 目的探讨抗纤维肌动蛋白抗体(AFA)阴性的自身免疫性肝炎(AIH)I型患者的临床特点。方法收集194例AIH-I型患者临床资料,按照检测结果将患者分为AFA阳性组124例和AFA阴性组70例,另外收集197例健康献血者作为对照组。采用ELSIA法检测AIH-I型患者AFA、抗肝肾微粒体I型抗体(LKM-1)、抗可溶性肝抗原/胰抗原抗体(SLA/LP)、抗肝细胞溶质抗原I型抗体(LC-1),间接免疫荧光法检测抗核抗体(ANA)、抗平滑肌抗体(ASMA)。对AIH-I型患者作肝脏病理组织学检查和生化检测。统计学处理采用t检验、秩和检验和χ2检验。结果 AIH-I型患者中AFA阴性与阳性的男女人数和年龄比较差异无统计学意义(P>0.05),自身抗体ANA、ASMA、LKM-1、SLA/LP和LC-1检出率差异也无统计学意义(P>0.05),但AFA阴性比阳性患者的急性发病人数百分率高(34.29%比12.90%,P<0.01),血清ALT高[(146.32±20.87)U/L比(128.26±38.09)U/L,P=0.008]、AST高[(124.55±23.54)U/L比(97.62±45.26)U/L,P=0.004]、胆红素高[(42.57±14.17)μmol/L比(29.73±10.17)μmol/L,P=0.001]、免疫球蛋白G低[(18.42±5.11)g/L比(26.36±6.92)g/L,P<0.01]。肝组织病理检测可见AFA阴性比阳性患者的浆细胞浸润率高(35.71%比21.77%,P=0.03)、中央肝小叶3区坏死率高(41.43%比11.29%,P<0.01)。结论AIH-I型患者中AFA阴性比阳性患者的急性发病率高,血胆红素、ALT和AST升高,免疫球蛋白G降低,肝组织浆细胞浸润率、肝小叶3区坏死率升高。 Objective To investigate the clinical features of autoimmune hepatitis type I (AIH-I)patients with negative anti-filamentous actin antibody (AFA).Methods A total of 194 AIH-I patients,including 124 positives (AFA≥30 U)and 70 negatives (AFA〈30 U),were enrolled and 197 healthy blood donors were set as controls.Enzyme-linked immune-sorbent assay (ELISA)was conducted to measure AFA,anti-liver-kidney microsome autoantibody type 1 (LKM-1),anti-soluble liver antigen/liver-pancreas (SLA/LP ) and anti-liver cytosol antibody type 1 (LC-1 ).Antinuclear antibodies (ANA)and anti-smooth muscle antibodies (SMA)were detected by indirect immunofluorescence assay (IFA). For statistically analyzing,liver biopsy of AIH-I patients and serum biochemical assessment of all research objects were performed.Results In AIH-I patients,no statistically significant differences in sex,age and positive rates of ANA, ASMA,LKM-1 ,SLA/LP and LC-1 were detected (P 〉0.05)between positive and negative group,respectively.Compared to those in AFA positive group,patients in AFA negative group had a significant higher percentage of acute onset (34.29% vs 12.90%,P 〈0.001),higher serum levels of alanine aminotransferase (ALT)(146.32±20.87 U/L vs 128.26±38.09 U/L,P =0.008),aspartate transaminase (AST)(124.55±23.54 U/L vs 97.62±45.26 U/L,P =0.004)and total bilirubin (TBil)(42.57±14.17 μmol/L vs 29.73 ±10.17 μmol/L,P =0.001 ),while with a significant lower serum level of IgG (18.42±5.11 g/L vs 26.36±6.92 g/L,P 〈0.001),respectively.Additionally,there were significantly higher incidences of plasma cell infiltration (35.71 % vs 21 .77%,P =0.03)and necrosis in central lobular zone 3 (41 .43% vs 11 .29%,P 〈0.001)in AFA negative group than those in AFA positive group.Conclusion Comparing to AFA positive patients with AIH-I,AFA negative patients displayed higher incidences of acute onset,plasma cell infiltration and necrosis in central lobular zone 3 with higher serum levels of TBil,ALT and AST but lower serum levels of IgG.
出处 《肝脏》 2015年第11期847-850,共4页 Chinese Hepatology
基金 国家中医临床研究基地业务建设科研专项课题(JDZX2012051)
关键词 肝炎 自身免疫性 I型 抗纤维肌动蛋白抗体 阴性 Hepatitis, autoimmune Type I Anti-filamentous actin antibodies Negative
  • 相关文献

参考文献18

  • 1Czaja AJ. Diagnosis and management of autoimmune hepatitis. Clin Liver Dis, 2015, 19:57-79.
  • 2Cui X, Zhang X, Yin Q, et al. Factin cytoskeleton reorganizationis associated with hepatic stellate cell activation. Mol Med Rep, 2014, 9 : 1641-1647.
  • 3Mehendiratta V, Mitroo P, Bombonati A, et al. Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis. Clin Gastroenterol Hepatol, 2009,7:98-103.
  • 4Hennes EM, Zeniya M, czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology, 2008, 48.. 169- 176.
  • 5Czaja AJ. Autoantibody-negative autoimmune hepatitis. Dig Dis Sei, 2012,57:610-624.
  • 6Qiu D,Wang Q,Wang H,et al. Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients. J Hepatol,2011,54 : 340-347.
  • 7Liberal R, Mieli-Vergani G, Vergani D. Clinical significance of autoantibodies in autoimmune hepatitis. J Autoimmun, 2013, 46: 17-24.
  • 8Nedim H, Loreto H. Autoimmune liver disease: novelties in management. Clin Res Hepatol Gastroenterol, 2014, 38:273-276.
  • 9Villalta D, Bizzaro N, Da Re M, et al. Diagnostic accuracy of four different immunological methods for the detection of anti-AFA autoantibodies in type 1 autoimmune hepatitis and other liver- related disorders. Autoimmunity, 2008, 41 : 105-110.
  • 10Jaskowski TD, Konnick EQ, Ashwood ER, et al. Prevalence of IgG autoantibody against AFA in patients suspected of having autoimmune or acute viral hepatitis. J Clin Lab Anal, 2007, 21: 249-253.

二级参考文献2

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部